C07K 2319/70
Containing domain for protein-protein interaction
Official title: containing domain for protein-protein interaction
C07K2319/70 (Containing domain for protein-protein interaction) appears on 3,471 US grants and 4,928 published applications in this corpus.
Search patents in C07K- Granted patents
- 3,471
- Published applications
- 4,928
- Assignees
- 1,907
- Inventors
- 8,500
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 6 | 0 |
| 1987 | 12 | 0 |
| 1988 | 17 | 0 |
| 1989 | 19 | 0 |
| 1990 | 12 | 0 |
| 1991 | 29 | 0 |
| 1992 | 44 | 0 |
| 1993 | 41 | 0 |
| 1994 | 35 | 0 |
| 1995 | 38 | 0 |
| 1996 | 49 | 0 |
| 1997 | 75 | 0 |
| 1998 | 88 | 0 |
| 1999 | 84 | 0 |
| 2000 | 69 | 0 |
| 2001 | 59 | 9 |
| 2002 | 41 | 71 |
| 2003 | 52 | 93 |
| 2004 | 29 | 63 |
| 2005 | 36 | 86 |
| 2006 | 38 | 65 |
| 2007 | 49 | 61 |
| 2008 | 36 | 68 |
| 2009 | 42 | 111 |
| 2010 | 56 | 99 |
| 2011 | 62 | 123 |
| 2012 | 53 | 118 |
| 2013 | 74 | 136 |
| 2014 | 97 | 180 |
| 2015 | 104 | 194 |
| 2016 | 150 | 281 |
| 2017 | 156 | 290 |
| 2018 | 167 | 371 |
| 2019 | 235 | 282 |
| 2020 | 253 | 353 |
| 2021 | 202 | 316 |
| 2022 | 206 | 355 |
| 2023 | 170 | 298 |
| 2024 | 178 | 344 |
| 2025 | 191 | 332 |
| 2026 | 108 | 229 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07K 2319/74Containing a fusion for binding to a cell surface receptorIndexing code1,627
- C07K 2319/735Containing a domain for self-assemblyIndexing code394
- C07K 2319/71Containing domain for transcriptional activaationIndexing code310
- C07K 2319/73Containing coiled-coiled motifIndexing code234
- C07K 2319/705Containing a protein-a fusionIndexing code139
- C07K 2319/72Containing sh2 domainIndexing code22
Recent patents
- Non-viral transcription activation domains and methods and uses related thereto6 Oct 2026US 12,753,212 B2Teknologian tutkimuskeskus VTT Oy
- Bacterial pilus protein complex FIMGT-DSF stabilized protein complexes for producing filamentous phages22 Sep 2026US 12,741,992 B2Roche Diagnostics Operations, Inc.
- Targeting of human interferon antagonists22 Sep 2026US 12,741,998 B2Centre Hospitalier Regional Universitaire De Montpellier
- Insulin-Fc fusion proteins and methods of use to treat cancer22 Sep 2026US 12,742,000 B2Akston Biosciences Corporation
- TNFR2 agonists with improved stability15 Sep 2026US 12,735,472 B2Universität Stuttgart
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Transcription factor 4 gene editing system8 Oct 2026US 2026/0306671 A1The Regents of the University of California
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Methods and compositions for in situ identification of protein-nucleic acid interaction sites8 Oct 2026US 2026/0308279 A1The Regents of the University of California
- Chimeric polypeptides, extracellular vesicles comprising the same, and uses thereof1 Oct 2026US 2026/0295068 A1Ciloa
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for producing members of specific binding pairs849US 5,733,743 ACambridge Antibody Technology Limited · 1998
- Hybrid immunoglobulins817US 5,116,964 AGenentech, Inc. · 1992
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998